On September 25, the 2024 World Medical Tourism and Global Health (Boao) Conference and Medical Health and Science Anti-Aging Development Forum were held in Haikou, Hainan Province. The forum was organized by the Organizing Committee of Medical Tourism and Global Health (Boao) Conference. Hainan Nanhai Health Industry Research Institute, Guhe Health Tourism Promotion Center (Hainan) Co., LTD. Co-organized by Hainan Non-Public Medical Institution Association and Hainan Science and Health Association. The forum attracted more than 200 well-known medical experts, scholars, and business representatives from both inside and outside Hainan Province, and gathered together to discuss cutting-edge topics in many fields such as medical health care, medical tourism, and scientific anti-aging.

With the core concept of "embracing change and reconstructing the future", this forum aims to gather wisdom from all sides, share the latest scientific research results and technical trends by experts and scholars in various fields, build an authoritative communication platform for the future development of the health industry, promote the exchange and collision of ideas, and jointly promote the innovation and development of the industry.

 
Professor Wang Jianxun, chief scientist of our company, was invited to attend the forum and shared the keynote speech of "Current Situation and Prospect of cell therapy", conducted in-depth discussion with many experts and scholars, and jointly explored the latest trend of technological innovation and industry development. Professor Wang Jianxun mentioned at the forum that as the core raw materials in the field of cell therapy, the quality and efficiency of viral vectors have a direct and significant impact on the industrialization process of cell therapy products. At present, China is facing the challenge of continuously expanding the size of cancer patients, while the supply of medical resources is relatively tight. As the only one-stop solution provider for cell and gene therapy in China that has mastered industrial-grade retroviral vector technology and has the absolute advantage of preparing high-quality cell therapy products, Shenzhen Cell Valley has successfully established a deep cooperation framework with a number of domestic public hospital institutions, and is committed to solving the bottleneck problem of cell and gene therapy products in production capacity and cost. To ensure that it can effectively benefit the wider population of cancer patients and bring new hope to patients.
At this forum, Shenzhen Cell Valley showed all participants the core technical advantages and forward-looking scientific research layout in the field of cell and gene therapy, laying a solid foundation for possible in-depth cooperation in the future.